BDBM299135 (6S,8R)-7-(2- fluoro-2- methylpropyl)-6- (2-methoxy-4- (2-(3- methoxyazetidin- 1-yl)ethoxy) phenyl)-8-methyl- 6,7,8,9- tetrahydro-3H- pyrazolo[4,3- f]isoquinoline::US10125135, Example 24

SMILES COc1cc(OCCN2CC(OC)C2)ccc1[C@@H]1c2ccc3[nH]ncc3c2C[C@@H](C)N1CC(C)(C)F

InChI Key InChIKey=KVKQMQGXQQTSJL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299135   

TargetEstrogen receptor(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 299135BDBM299135(US10125135, Example 24 | (6S,8R)-7-(2- fluoro-2- m...)
Affinity DataIC50: 3.70nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent